HTHui Yin Tan

Hui Yin Tan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hui Yin Tan has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Synthesis, in vitro antimalarial activity, cytotoxicity, and pharmacokinetic evaluation of chalcone-derived thiosemicarbazones

    by Sheng Zhou Ho, Ming Yueh Tan, Hui Yin Tan, Siow Ping Tan, Siew Lee Cheong, Sook Yee Liew, Sang Long Tan, Yee Ling Lau, Yee Ling Ng

    Six novel chalcone-derived thiosemicarbazones ( L1 - L6 ) were synthesised and characterised by FT-IR, DSC, elemental CHNS analysis, Q-TOF LC/MS, 1 H and 13 C NMR spectroscopy, with the structure of L3 further confirmed by single-crystal X-ray crystallography. In vitro evaluation against chloroquine-sensitive P. falciparum (3D7 strain) revealed potent antimalarial activity (IC 50 = 6.0–205.1 µM), with L4 exhibiting the highest potency (IC 50 = 6.0 µM). Cytotoxicity screening revealed that all compounds were non-toxic to human MRC-5 cells at a concentration of 200 µM. The predicted pharmacokinetic profiles revealed that the superior potency of L4 is underpinned by its high lipophilicity (LogP = 5.7) and low systemic clearance, which likely facilitates parasite penetration and sustained exposure. These results highlight L4 as a promising antimalarial lead compound worthy of further development.


  • Assessment of eating jet lag, chrono-nutritional patterns and sleep profiles in the adult population: findings from a cross-sectional study

    by Guey Yong Chong, Satvinder Kaur, Ruzita Abd Talib, See Ling Loy, Hui Yin Tan, Woan Yie Siah, Fatin Hanani Mazri, Hui Chin Koo


  • Exploring the Association of Sleep Profiles With Plasma Glycaemic Outcomes and 24‐h Interstitial Glucose Levels in Adults With Prediabetes: Findings From Chrono‐ DM Study

    by Guey Yong Chong, Satvinder Kaur, Ruzita Abd Talib, See Ling Loy, Hui Yin Tan, Rosmiza Binti Abdullah, Hanisah Binti Mahmud, Woan Yie Siah, Chee Cheong Kee, Hui Chin Koo

    Sleep profiles, including chronotype, sleep duration and sleep–wake time, may affect glycaemic outcomes. However, their associations with plasma glycaemic outcomes and 24‐h interstitial glucose levels in individuals with prediabetes remains ambiguous. This study aimed to examine the association between sleep profiles and glycaemic outcomes in adults with prediabetes. Chronotype was assessed using the Malay‐translated Munich Chronotype Questionnaire. Glycaemic outcomes, including fasting plasma glucose (FPG), 2‐h postprandial glucose (2hPPG), glycated haemoglobin (HbA1c) levels and 24‐h glucose profiles derived from seven‐day continuous glucose monitoring (CGM). Generalised linear models and generalised estimating equations were used and adjusting for potential confounders. A total of 120 participants (mean age: 54 ± 15 years) were categorised as morning (18.4%), intermediate (60.8%) or evening (20.8%) chronotypes. Evening chronotypes demonstrated greater weekday‐weekend discrepancy in awake time (0.7 h [±1.1 h]), indicating higher social jet lag. Each additional hour of jet lag in awake time was associated with a 0.28 mmol/L reduction in 2hPPG levels (95% CI: −0.49, −0.08), reflecting compensatory catch‐up sleep on weekends. Longer sleep time was positively associated more time spent within the target glucose range (3.9–7.8 mmol/L) (β: 0.58, 95% CI: 0.06, 1.10), while evening chronotype showed higher 24‐h mean glucose levels (β: 0.65 mmol/L, 95% CI: 0.22, 1.12). Evening chronotype and shorter sleep duration were associated with adverse glycaemic outcomes, while the unexpected inverse association between awake‐time jet lag and 2hPPG may reflect short‐term catch‐up sleep rather than a protective effect. These findings highlight the importance of addressing sleep regularity in lifestyle interventions for prediabetes management.


  • Enhancing Growth and Modulation of Gut Microbiota in Red Hybrid Tilapia (Oreochromis sp.) with Host-Associated Leuconostoc lactis as Feed Additive

    by S. Y. Hew, P. Y. Tan, K. Zhao, H. Y. Tan

    Economic sustainability and the emergence of infectious diseases remain critical challenges in tilapia aquaculture. Lactic acid bacteria (LAB) are well-known feed additives with probiotic effects in improving overall performance of livestock. This study evaluated the effects of host-associated probiotic, Leuconostoc lactis TARicum AI2, on growth performance, antioxidant, immune responses, and gut microbiota of red hybrid tilapia (Oreochromis sp.) by conducting an 86-day feeding trial. The probiotic, previously characterised for its beneficial traits, was coated on commercial feed at a concentration of 109 CFU g−1. Results showed tilapia fed with probiotic had significant improvement in feed conversion ratio (FCR) and protein efficiency ratio (PER) compared to the control group. Upregulation of cytokine expressions was observed in the probiotic group. Gut microbiota analysis revealed an increased abundance of the genera Clostridium and Leuconostoc in the probiotic-fed tilapia. Beta-diversity indices proved exclusive groups of bacteria present in specific diet only. In conclusion, L. lactis strain TARicum AI2 is a potential probiotic candidate in promoting growth in tilapia as the results suggested it could improve FCR and PER. Feed with lower FCR and higher PER could help tilapia farmers in reducing feed cost, which accounted for the major portion of their production cost. This further enables them to achieve cost-effective, enhanced productivity and economic sustainability in a long run.


  • Open Access

    Scoping review protocol: The chrononutrition factors in association with glycemic outcomes in adult population

    by Guey Yong Chong, Satvinder Kaur, Ruzita Abd Talib, See Ling Loy, Hui Yin Tan, Kok Hoe Wilfred Mok, Ling-Wei Chen, Woan Yie Siah, Yin Yin Chee, Ee Mun June Lem, et al.

    Chrononutrition, which examines the relationship between circadian rhythms and nutrition, has been associated with glycemic outcomes in adults. However, published data on delayed meal timing, increased meal frequency and frequent breakfast skipping have shown inconsistent glycemic outcomes due to variations in methodologies and populations studied. This review presents the scoping review protocol designed to map the evidence on the association between chrononutrition factors and glycemic outcomes in adults. The methodology framework from Arksey and O’Malley will be adapted for this scoping review. Relevant publications will be searched on databases including PubMed, EBSCO Host, ProQuest Central, MEDLINE & Ovid, Scopus and Web of Science. This review focuses on original articles published from January 2014 to 2024, involving participants aged 18 years and older, published in English, and encompassing experimental and observational studies. A comprehensive keyword search strategy will be developed to identify relevant articles. Two reviewers will independently screen the abstracts and titles to determine the eligibility. Subsequently, the full text of potentially eligible articles will be reviewed by additional independent reviewer for final inclusion, with full text screening being verified by two reviewers, and interrater reliability will be conducted. Data from the included articles will be extracted, collated and charted to summarize the relevant methods, outcomes and key findings. This Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist will be used to guide the development of protocol. This scoping review represents a novel approach to summarize the association between chrononutrition factors and glycemic outcomes among adults. We anticipate the findings of the review will provide stakeholder with crucial evidence-based information for development of effective intervention to manage glycemic outcome in adults. This protocol has been prospectively registered in the Open Science Framework (https://doi.org/10.17605/OSF.IO/PA9BU).

  • Traditional Uses, Phytochemistry and Pharmacological Activities of Tradescantia spathacea-X

    by Siow-Ping Tan, Xin-Yi Keng, Chi-Wah Bryan Lim, Hui-Yin Tan

    Tradescantia spathacea has been traditionally employes for treating various conditions, including coughs, fevers, wounds, inflammation, and oxidative-related diseases. This paper presents a comprehensive review of its traditional uses, alongside an examination of phytochemical and pharmacological studies aimed at validating ethnopharmacological practices. A systematic search across electronic databases using relevant keywords yielded 845 articles, of which 70 articles were reviewed. T. spathacea exhibits a broad spectrum of pharmacological activities, as evidenced by in vivo studies demonstrating hepatoprotective, anti-diabetic, anti-inflammatory and anticancer effects. In vitro studies further support its medicinal properties, including antimicrobial, anti-viral, antioxidant, anti-helminthic, antimutagenic, antigenotoxic and cytotoxic activities. While these modern pharmacological properties substantiate traditional uses, further research is essential to validate them and develop safe and effective therapeutic formulations. Further investigations should focus on bioassay-guided isolation of bioactive compounds, extensive pharmacological, clinical, and toxicological studies, incorporating adequate data replication, proper standardization and control groups, and the selection of reasonable doses or concentrations of extracts and controls.


  • Open Access

    Anti-Hyperuricemic Effect of Ethyl Acetate Sub-Fractions from Chrysanthemum morifolium Ramat. Dried Flowers on Potassium Oxonate-Induced Hyperuricemic Rats

    by Teng Lit Ng, Khye Er Loh, Sheri-Ann Tan, Hui Yin Tan, Chen Son Yue, Sze Ping Wee, Zi Tong Tey

    Xanthine oxidase (XO) plays an important role in purine degradation in humans. The study aimed to determine the XO inhibitory potential of Chrysanthemum morifolium dried flower ethyl acetate sub-fractions and its anti-hyperuricemic effect in rat models. Bioassay-guided fractionation based on XO inhibitory assay was employed to obtain bioactive fractions and sub-fractions. In vitro cytotoxicity and cellular antioxidant capacity of the sub-fraction and its mode of XO inhibition were also investigated. The anti-hyperuricemic effect of the bioactive sub-fraction was investigated using rat models via oral consumption, and followed by an XO mRNA gene expression study. The compounds in the bioactive sub-fractions were identified putatively using HPLC-Q-TOF-MS/MS. Ethyl acetate (EtOAc) fraction exhibited the highest XO inhibition among the fractions. It was further fractionated into 15 sub-fractions. F10 exhibited high XO inhibitory activity, cellular pro-proliferative effect, and intracellular antioxidant activity among the sub-fractions tested. This sub-fraction was non-cytotoxic at 0.1–10 µg/mL, and very effective in lowering serum and urine uric acid level in rat models upon oral consumption. A total of 26 known compounds were identified and seven unknown compounds were detected via HPLC-Q-TOF–MS/MS analysis. The possible mechanisms contributing to the anti-hyperuricemic effect were suggested to be the non-competitive inhibition of XO enzyme, XO gene expression down-regulation, and the enhancement of uric acid excretion.


  • Open Access

    Cholesterol homeostasis associated with probiotic supplementation in vivo

    by Pei Shan Lim, Chui Fung Loke, Yin Wan Ho, H.Y. Tan

    Aims To determine the mechanism underlying the serum cholesterol reduction effect by probiotics isolated from local fermented tapioca (Tapai). Methods and Results Lactic acid bacteria strains were isolated and examined for acid tolerance, bile salt resistance and hypocholesterolemic properties. Among the isolates, Lact. plantarum TAR4 showed the highest cholesterol reduction ability (48.01%). The focus in the in vivo trial was to elucidate the cholesterol balance from findings pertaining to serum cholesterol reduction in rat model fed with high fat diet via oral administration. Rats fed with high‐cholesterol diet supplemented with Lact. plantarum TAR4 showed significant reduction in serum total cholesterol (29.55%), serum triglyceride (45.31%) and liver triglyceride (23.44%) as compared to high‐cholesterol diet (HCD) group. There was a significant increment in faecal triglyceride (45.83%) and faecal total bile acid (384.95%) as compared to HCD group. Conclusions The findings showed that probiotic Lact. plantarum TAR4 supplementation reduced the absorption of bile acids for enterohepatic recycling and increase the catabolism of cholesterol to bile acids and not by suppressing the rate of cholesterol synthesis. Significance and Impact of Study Probiotics supplements could provide a new non‐pharmacological alternative to reduce cardiovascular risk factors.


  • Open Access

    Changes in rumen protozoal community by condensed tannin fractions of different molecular weights from aLeucaena leucocephalahybridin vitro

    by M. Saminathan, H.M. Gan, N. Abdullah, C.M.V.L. Wong, S.K. Ramiah, H.Y. Tan, C.C. Sieo, Y.W. Ho

    Aims To evaluate the effects of condensed tannins (CTs) fractions of differing molecular weights (MWs) from a Leucaena leucocephala hybrid‐Rendang on the rumen protozoal community in vitro. Methods and Results The effects of unfractionated CTs (F0) and CT fractions of different MWs (F1 > F2 > F3 > F4 > F5) on protozoal population and community were evaluated in vitro using rumen microbes and ground guinea grass as the substrate. Higher‐MW CT fractions F1 and F2 significantly (P < 0·05) decrease the number of ciliate protozoa. The real‐time PCR analysis showed that the total protozoa was significantly (P < 0·05) lower in F0 and all CTs with fractions F1 and F2 having the lowest value. High‐throughput sequencing of the partial 18S rRNA gene showed that the genus Entodinium significantly (P < 0·05) decreased with increasing MWs of CT, whereas Anoplodinium‐Diplodinium were significantly (P < 0·05) increased. Inclusion of the highest MW CT fraction F1 decreased the relative abundance of the minor genera such as Eudiplodinium and Polyplastron compared to the control and CT fractions F2–F5. Conclusion CTs of differing MWs could reduce and alter the rumen protozoa population in vitro. This effect was more pronounced for higher‐MW CTs. Significance and Impact of the Study The high MW CTs should be considered as a feed supplement in the ruminant diet to reduce the protozoal population which are known to be associated with methanogens as a means to mitigate methane production in the rumen.